VR

Viswanath Reddy Reddyvari

Active Director Designated Partner DIN 09188800
DIN 09188800 First appointment May 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Viswanath Reddy Reddyvari

Data last updated:

Viswanath Reddy Reddyvari is a Designated Partner at Robert Roy Pharmaceuticals Llp (since 2021). The company operates in Chemicals.

DIN 09188800
Primary Designation Designated Partner
Industry Chemicals
First Appointment 31 May 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner31 May 20212021Active

Board colleagues of Viswanath Reddy Reddyvari

NameDINCompanyDesignation
Mukesh Sayyam Jain09188799Robert Roy Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Robert Roy Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Viswanath Reddy Reddyvari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Viswanath Reddy Reddyvari

Viswanath Reddy Reddyvari currently holds 1 directorship: Robert Roy Pharmaceuticals Llp (Designated Partner, since 31 May 2021).

Viswanath Reddy Reddyvari was first appointed on 31 May 2021 as Designated Partner at Robert Roy Pharmaceuticals Llp.

The current boards of Viswanath Reddy Reddyvari's companies include Mukesh Sayyam Jain (Robert Roy Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available